|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
2
|
|
pubmed:dateCreated |
2009-12-22
|
|
pubmed:abstractText |
Therapy with anaferon (pediatric formulation) during the acute period of calicivirus infection shortened the duration of the main symptoms of the disease and period of virus release. Changes in the immunological status included increased production of IgA and IgM and activation of IFN-alpha synthesis.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Aug
|
|
pubmed:issn |
1573-8221
|
|
pubmed:author |
|
|
pubmed:issnType |
Electronic
|
|
pubmed:volume |
148
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
287-90
|
|
pubmed:meshHeading |
pubmed-meshheading:20027349-Acute Disease,
pubmed-meshheading:20027349-Adolescent,
pubmed-meshheading:20027349-Antibodies,
pubmed-meshheading:20027349-Antiviral Agents,
pubmed-meshheading:20027349-Caliciviridae Infections,
pubmed-meshheading:20027349-Child,
pubmed-meshheading:20027349-Child, Preschool,
pubmed-meshheading:20027349-Enzyme-Linked Immunosorbent Assay,
pubmed-meshheading:20027349-Female,
pubmed-meshheading:20027349-Humans,
pubmed-meshheading:20027349-Immune System,
pubmed-meshheading:20027349-Immunoglobulin A,
pubmed-meshheading:20027349-Immunoglobulin M,
pubmed-meshheading:20027349-Immunophenotyping,
pubmed-meshheading:20027349-Infant,
pubmed-meshheading:20027349-Interferon Inducers,
pubmed-meshheading:20027349-Interferon-alpha,
pubmed-meshheading:20027349-Intestinal Diseases,
pubmed-meshheading:20027349-Male,
pubmed-meshheading:20027349-Treatment Outcome
|
|
pubmed:year |
2009
|
|
pubmed:articleTitle |
Clinical and immunological efficiency of anaferon (pediatric formulation) in calicivirus infection in children.
|
|
pubmed:affiliation |
Institute of Children Infections, Federal Agency for Health Care and Social Development, St. Petersburg.
|
|
pubmed:publicationType |
Journal Article,
Randomized Controlled Trial
|
